Intensity Therapeutics Says Cancer Drug Candidate Shows Benefits in Phase 2 Trial
Intensity Therapeutics Says Cancer Drug Candidate Shows Benefits in Phase 2 Trial
Intensity Therapeutics表示其癌症药物候选者在第二阶段试验中显示出益处。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间